Dow Chemical announced plans to build and operate a pilot-scale algae-based integrated biorefinery with algenol biofuels. The company plans to develop the advanced materials and specialty films for the photobioreactor system. The facility is planned to be located at Dow's Freeport, Texas, U.S. site.
Part 1: Building a Business Case for Pharma 4.0
A new Horváth study based on interviews with CxOs of Europe’s top chemical corporations reveals: The majority of board members expects no or only weak growth for the current year.
How AI and Robotics are reshaping the race for materials discovery.
The ECA Foundation, one of the most important not-for-profit organizations for regulatory expertise in the pharmaceutical industry, aims to become the largest independent GMP/GDP organization in the world.
The first quarter of 2025 highlights a continued divergence between the European and US chemical industries.
